Enlivex Therapeutics Valuation
| ENLV Stock | USD 1.50 0.18 13.64% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Enlivex Therapeutics shows a prevailing Real Value of $4.11 per share. The current price of the firm is $1.5. Our model computes the value of Enlivex Therapeutics from reviewing the firm fundamentals such as Shares Owned By Institutions of 8.93 %, shares owned by insiders of 11.80 %, and Current Valuation of (1.74 M) as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise buying undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting Enlivex Therapeutics' valuation include:
Price Book 0.7578 | Enterprise Value -1.7 M | Enterprise Value Ebitda (0.13) |
Undervalued
Today
Please note that Enlivex Therapeutics' price fluctuation is very risky at this time. Calculation of the real value of Enlivex Therapeutics is based on 3 months time horizon. Increasing Enlivex Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Enlivex Therapeutics is useful when determining the fair value of the Enlivex stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Enlivex Therapeutics. Since Enlivex Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Enlivex Stock. However, Enlivex Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.5 | Real 4.11 | Target 12.0 | Hype 1.37 |
The real value of Enlivex Stock, also known as its intrinsic value, is the underlying worth of Enlivex Therapeutics Company, which is reflected in its stock price. It is based on Enlivex Therapeutics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Enlivex Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Enlivex Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Enlivex Therapeutics helps investors to forecast how Enlivex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Enlivex Therapeutics more accurately as focusing exclusively on Enlivex Therapeutics' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Enlivex Therapeutics' intrinsic value based on its ongoing forecasts of Enlivex Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Enlivex Therapeutics' closest peers. When choosing an evaluation method for Enlivex Therapeutics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Enlivex Therapeutics Investments |
|
Enlivex Valuation Trend
Knowing Enlivex Therapeutics' actual value is paramount for traders to make sound investment determinations. Enlivex Therapeutics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Enlivex Therapeutics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Enlivex Therapeutics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Enlivex Market Cap
Enlivex Therapeutics is one of the top stocks in market capitalization category among related companies. Market capitalization of Information Technology industry is currently estimated at about 2.43 Billion. Enlivex Therapeutics claims roughly 24.55 Million in market capitalization contributing just under 2% to equities under Information Technology industry.Enlivex Therapeutics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Enlivex Therapeutics's current stock value. Our valuation model uses many indicators to compare Enlivex Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enlivex Therapeutics competition to find correlations between indicators driving Enlivex Therapeutics's intrinsic value. More Info.Enlivex Therapeutics is one of the top stocks in price to earning category among related companies. It is one of the top stocks in price to book category among related companies . Price To Book Ratio is likely to drop to 1.58 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Enlivex Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Enlivex Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Enlivex Therapeutics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Enlivex Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Enlivex Therapeutics and how it compares across the competition.
About Enlivex Therapeutics Valuation
The stock valuation mechanism determines the current worth of Enlivex Therapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Enlivex Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Enlivex Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Enlivex Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Enlivex Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Enlivex Therapeutics. We calculate exposure to Enlivex Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Enlivex Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -835 K | -793.2 K | |
| Pretax Profit Margin | (4.67) | (4.91) | |
| Operating Profit Margin | (3.87) | (4.06) | |
| Net Loss | (5.48) | (5.75) | |
| Gross Profit Margin | 0.79 | 0.70 |
8 Steps to conduct Enlivex Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Enlivex Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Enlivex Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Enlivex Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Enlivex Therapeutics' revenue streams: Identify Enlivex Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Enlivex Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Enlivex Therapeutics' growth potential: Evaluate Enlivex Therapeutics' management, business model, and growth potential.
- Determine Enlivex Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Enlivex Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Enlivex Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Enlivex Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 18.6 M |
Enlivex Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Enlivex Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Enlivex we look at many different elements of the entity such as Enlivex's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Enlivex Therapeutics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Enlivex Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Enlivex Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Enlivex Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Enlivex Therapeutics' worth.When determining whether Enlivex Therapeutics is a strong investment it is important to analyze Enlivex Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Enlivex Therapeutics' future performance. For an informed investment choice regarding Enlivex Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enlivex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Enlivex Stock please use our How to Invest in Enlivex Therapeutics guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Enlivex Stock analysis
When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Enlivex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enlivex Therapeutics. If investors know Enlivex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enlivex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Return On Assets (0.30) | Return On Equity (0.67) |
The market value of Enlivex Therapeutics is measured differently than its book value, which is the value of Enlivex that is recorded on the company's balance sheet. Investors also form their own opinion of Enlivex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Enlivex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enlivex Therapeutics' market value can be influenced by many factors that don't directly affect Enlivex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enlivex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enlivex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enlivex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.